Your browser doesn't support javascript.
loading
Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Burger, Robert A; Deng, Wei; Makker, Vicky; Collins, Yvonne; Gray, Heidi; Debernardo, Robert; Martin, Lainie P; Aghajanian, Carol.
Affiliation
  • Burger RA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA 19104, United States of America. Electronic address: robert.burger@uphs.upenn.edu.
  • Deng W; NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park, Buffalo, NY 14263, United States of America. Electronic address: wdeng@gogstats.org.
  • Makker V; Department of Medicine, Memorial Sloan Kettering Cancer, New York, NY 10065, United States of America. Electronic address: makkerv@mskcc.org.
  • Collins Y; Department of Obstetrics & Gynecology, University of Illinois at Chicago CCOP, Chicago, IL 60612, United States of America. Electronic address: yvonne.collins-md@advocatehealth.com.
  • Gray H; Dept. of OB/GYN, Washington University School of Medicine, Seattle, WA 98195, United States of America. Electronic address: hgray@u.washington.edu.
  • Debernardo R; Department of Obstetrics & Gynecology, Case Western University Hospital, Cleveland, OH 44106, United States of America. Electronic address: debernr@ccf.org.
  • Martin LP; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, United States of America. Electronic address: lainie.martin@fccc.edu.
  • Aghajanian C; Department of Medicine, Memorial Sloan Kettering Cancer, New York, NY 10065, United States of America. Electronic address: aghajanc@MSKCC.ORG.
Gynecol Oncol ; 150(3): 466-470, 2018 09.
Article in En | MEDLINE | ID: mdl-30041929
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Peritoneal Neoplasms / Recombinant Fusion Proteins / Immunoglobulin Fc Fragments / Carcinoma / Activin Receptors, Type II / Fallopian Tube Neoplasms / Neoplasm Recurrence, Local / Antineoplastic Agents Type of study: Guideline Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Peritoneal Neoplasms / Recombinant Fusion Proteins / Immunoglobulin Fc Fragments / Carcinoma / Activin Receptors, Type II / Fallopian Tube Neoplasms / Neoplasm Recurrence, Local / Antineoplastic Agents Type of study: Guideline Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2018 Type: Article